help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amino, N.
Right arrow Articles by Kumahara, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amino, N.
Right arrow Articles by Kumahara, Y.

Journal of Clinical Endocrinology & Metabolism, Vol 51, 1232-1234, Copyright © 1980 by Endocrine Society

ARTICLES

Exophthalmos in autoimmune thyroid disease

N Amino, T Yuasa, Y Yabu, K Miyai and Y Kumahara

Protrusion of the eyes of patients with autoimmune thyroid disease was compared with that of healthy subjects. The mean values for protrusion in patients with thyrotoxic Graves' disease and Hashimoto's disease and in healthy subjects were 16.6 +/- 2.1 mm (mean +/- SD; n = 122), 14.2 +/- 1.8 mm (n = 100), and 13.9 +/- 1.9 mm (n = 558), respectively. The value of Graves' disease was significantly different from that for healthy subjects (P < 0.001). Individual values for protrusion showed a similar normal distribution in these three groups, but were displaced to higher values as a whole in Graves' disease. These results, which suggest that almost all patients with Graves' disease have exophthalmos, do not support the idea that Graves' ophthalmopathy is a distinct single autoimmune disease.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. L. Wemeau, P. Caron, A. Beckers, V. Rohmer, J. Orgiazzi, F. Borson-Chazot, M. Nocaudie, P. Perimenis, S. Bisot-Locard, I. Bourdeix, et al.
Octreotide (Long-Acting Release Formulation) Treatment in Patients with Graves' Orbitopathy: Clinical Results of a Four-Month, Randomized, Placebo-Controlled, Double-Blind Study
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 841 - 848.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
J M Kim, L LaBree, L Levin, and S E Feldon
The relation of Graves' ophthalmopathy to circulating thyroid hormone status
Br. J. Ophthalmol., January 1, 2004; 88(1): 72 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
K. Kazuo, T. Fujikado, G. Ohmi, J. Hosohata, and Y. Tano
Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients
Br. J. Ophthalmol., December 1, 1997; 81(12): 1080 - 1083.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society